Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/11/7/1650 |
id |
doaj-6d518439dcc849f7bd8907bb2ab5f9a5 |
---|---|
record_format |
Article |
spelling |
doaj-6d518439dcc849f7bd8907bb2ab5f9a52020-11-25T01:20:41ZengMDPI AGNutrients2072-66432019-07-01117165010.3390/nu11071650nu11071650Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population PerspectiveCostanza Varesio0Ludovica Pasca1Stefano Parravicini2Martina Paola Zanaboni3Elena Ballante4Silvia Masnada5Cinzia Ferraris6Simona Bertoli7Anna Tagliabue8Pierangelo Veggiotti9Valentina De Giorgis10Department of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyBioData Science Center, IRCCS Mondino Foundation, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyHuman Nutrition and Eating Disorder Research Center, Department of Public Health, Experimental and Forensic Medicine University of Pavia, 27100 Pavia, ItalyInternational Center for the Assessment of Nutritional Status (ICANS), Department of Food Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Sandro Botticelli 21, 20133 Milan, ItalyHuman Nutrition and Eating Disorder Research Center, Department of Public Health, Experimental and Forensic Medicine University of Pavia, 27100 Pavia, ItalyPediatric Neurology Unit, Vittore Buzzi Hospital, Via Lodovico Castelvetro 32, 20154 Milan, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyBackground: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized cohort of patients affected by GLUT1DS treated with KD, evaluating factors that can influence patients’ and parents’ quality of life perception. Methods: This is a double center exploratory research study. A postal survey with auto-administrable questionnaires was conducted among 17 subjects (aged 3−22 years) with diagnosis of GLUT1DS, receiving a stable KD treatment for more than 1 year. The Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales was adopted. Clinical variables analyzed in relation to quality of life were frequency of epileptic seizures and movement disorder since KD introduction, presence of intellectual disability (ID), and KD ratio. Results: Quality of life global scores were impaired both in parents’ and children’s perspectives, with a significant concordance. Taking into consideration subscales, the average was 64.17 (range 10−100) for physical functioning, 74.23 (range 30−100) for emotional functioning, 62.64 (range 10−100) for social functioning, and 56 (range 15−92) for school functioning. Conclusions: In patients with GLUT1DS the quality of life perception is comparable to that of other patients with chronic disease. In our sample, the presence of movement disorder seems to be a crucial element in quality of life perception.https://www.mdpi.com/2072-6643/11/7/1650ketogenic diet treatmentGLUT1 deficiency syndromehealth related quality of lifePedsQol 4.0 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Costanza Varesio Ludovica Pasca Stefano Parravicini Martina Paola Zanaboni Elena Ballante Silvia Masnada Cinzia Ferraris Simona Bertoli Anna Tagliabue Pierangelo Veggiotti Valentina De Giorgis |
spellingShingle |
Costanza Varesio Ludovica Pasca Stefano Parravicini Martina Paola Zanaboni Elena Ballante Silvia Masnada Cinzia Ferraris Simona Bertoli Anna Tagliabue Pierangelo Veggiotti Valentina De Giorgis Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective Nutrients ketogenic diet treatment GLUT1 deficiency syndrome health related quality of life PedsQol 4.0 |
author_facet |
Costanza Varesio Ludovica Pasca Stefano Parravicini Martina Paola Zanaboni Elena Ballante Silvia Masnada Cinzia Ferraris Simona Bertoli Anna Tagliabue Pierangelo Veggiotti Valentina De Giorgis |
author_sort |
Costanza Varesio |
title |
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_short |
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_full |
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_fullStr |
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_full_unstemmed |
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_sort |
quality of life in chronic ketogenic diet treatment: the glut1ds population perspective |
publisher |
MDPI AG |
series |
Nutrients |
issn |
2072-6643 |
publishDate |
2019-07-01 |
description |
Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized cohort of patients affected by GLUT1DS treated with KD, evaluating factors that can influence patients’ and parents’ quality of life perception. Methods: This is a double center exploratory research study. A postal survey with auto-administrable questionnaires was conducted among 17 subjects (aged 3−22 years) with diagnosis of GLUT1DS, receiving a stable KD treatment for more than 1 year. The Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales was adopted. Clinical variables analyzed in relation to quality of life were frequency of epileptic seizures and movement disorder since KD introduction, presence of intellectual disability (ID), and KD ratio. Results: Quality of life global scores were impaired both in parents’ and children’s perspectives, with a significant concordance. Taking into consideration subscales, the average was 64.17 (range 10−100) for physical functioning, 74.23 (range 30−100) for emotional functioning, 62.64 (range 10−100) for social functioning, and 56 (range 15−92) for school functioning. Conclusions: In patients with GLUT1DS the quality of life perception is comparable to that of other patients with chronic disease. In our sample, the presence of movement disorder seems to be a crucial element in quality of life perception. |
topic |
ketogenic diet treatment GLUT1 deficiency syndrome health related quality of life PedsQol 4.0 |
url |
https://www.mdpi.com/2072-6643/11/7/1650 |
work_keys_str_mv |
AT costanzavaresio qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT ludovicapasca qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT stefanoparravicini qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT martinapaolazanaboni qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT elenaballante qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT silviamasnada qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT cinziaferraris qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT simonabertoli qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT annatagliabue qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT pierangeloveggiotti qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT valentinadegiorgis qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective |
_version_ |
1725132706805710848 |